TP53 and cancer: Similar results were also observed in p53-null H1299 lung cancer cells (Supplementary Figures 5d and e), suggesting that the p53-R273H contact mutant, but not the p53-R175H conformational mutant, confers anoikis resistance in human cancer cells.